<DOC>
	<DOCNO>NCT00753103</DOCNO>
	<brief_summary>The purpose study determine whether Infliximab ( monoclonal anti-tumour necrosis factor alpha antibody ) safe effective treatment anti-neutrophil cytoplasm antibody ( ANCA ) associate vasculitis .</brief_summary>
	<brief_title>Anti-Cytokine Therapy Vasculitis</brief_title>
	<detailed_description>Anti-neutrophil cytoplasm antibody ( ANCA ) associate vasculitis life-threatening systemic inflammatory autoimmune disease . Current treatment regime use corticosteroid cyclophosphamide improve patient survival associate treatment associate morbidity mortality . Tumour necrosis factor alpha ( TNF ) proinflammatory cytokine implicate pathogenesis ANCA vasculitis . Anti-TNF therapy use successfully management inflammatory autoimmune disease . This phase II cohort study design investigate safety efficacy anti-TNF monoclonal antibody ( Infliximab ) therapy patient ANCA associate vasculitis use addition standard immunosuppressive therapy .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Either newly diagnose relapse ANCA associate vasculitis ( Wegener 's granulomatosis , microscopic polyangiitis , renal limited vasculitis ) Active infection Malignancy Pregnancy Diagnosis ChurgStrauss syndrome antiglomerular basement membrane antibody disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Infliximab</keyword>
	<keyword>Vasculitis</keyword>
	<keyword>antitnf monoclonal antibody</keyword>
</DOC>